Program 2023 - Swiss Biotech Day

Monday, April 24, 2023

09:30

Early bird badge pick up (advised)
Entrance

11:00-12:00

General Assembly (by invitation only)
Room Sydney

11:00

Registration open
Entrance

12:00-12:45

Press Conference
Room Rio

12:00-18:30

Exhibition and poster presentation throughout the day
Foyer 2nd floor and Room Singapore

Exhibitors

12:00-19:00

Partnering throughout the day
Room San Francisco

Partnering

Partnering

The partnering will open in March 2023.

Once you have registered, you will receive an automated acknowledgement to the email address you have registered with. We will create a free account in the Swiss Biotech Day online partnering system called “Hello Partnering” provided by BIOTECH GATE and VENTURE VALUATION. Once your account is set up you will receive a confirmation email containing your login details.

Meetings will be held on-site only in a dedicated area of the conference.

presented by

12:00-19:00

Global Village with Round Table Discussions throughout the day
Room San Francisco

Global Village

Welcome to the Global Village at the Swiss Biotech Day 2023.

The Global Village platform is a dedicated offering for national and regional foreign biotech clusters which intend to develop and strengthen long-term and sustainable business ties and collaborations with various stakeholders of the Swiss biotech ecosystem. It is an integral part of the Swiss Biotech Day as the anchor event for the Global Village platform. International delegations who participate in the Global Village platform benefit from several tailormade opportunities in addition to the classical offerings of the Swiss Biotech Day: they present themselves through dedicated delegation booths in the Global Village area of the Swiss Biotech Day, they participate in a small roundtable discussion tailormade for each delegation and they will be part of the international reception for foreign delegations. In addition, delegations may participate in dedicated site visits of selected biotech hotspots in Switzerland directly after the Swiss Biotech Day.

Delegations include a cross-section of their respective biotech hub including C-level entrepreneurs, venture builders and investors, researchers and academics, leading hospital representatives, clinical investigators and CROs, government bodies and economic development agencies to representatives of incubators and accelerators.

The Global Village Platform is jointly presented by the Swiss Biotech Association and Switzerland Global Enterprise.
All participants of the Swiss Biotech Day are welcome to explore the Global Village booths and engage with delegation members in the Global Village area of the Swiss Biotech Day.

presented by

Round Table Discussions

Round Table Discussions

Please join us for roundtable discussions, aiming to facilitate partnerships and connect international representatives with the Swiss biotech industry for research, corporate collaborations, policy-making and investments.

Join us at a bilateral roundtable discussion or have a drink with us at the international reception in the Global Village and network with the global biotech community!

Time

14:45-15:15

15:30-16:00

16:15-16:45

17:00-17:30

Country

13:00-14:30

Plenary Session I
Room Montreal

Plenary Session I

Moderator: Monika Jones

13:00

Welcome Address
Michael Altorfer, CEO, Swiss Biotech Association

13:10

Celebrating 25 years of biopharmaceutical innovation: From treating symptoms towards precision medicine
Introduction: Patrick Amstutz, CEO Molecular Partners, President of the Swiss Biotech Association
Moderation: Michael Hengartner
Martine Clozel, co-Founder and CSO, Idorsia
Markus Goebel, ex Novartis Venture Fund
Dominik Escher, Managing Partner, Pureos Bioventures
Lutz Hegemann, President Global Health & Sustainability, Novartis
Andreas Plückthun, Professor of Biochemistry, University of Zurich

14:30-15:00

Coffee Break

from 14:45

Parallel Tracks

Advanced Biotech Companies (Room Osaka)

14:45-15:00
Stücki Park

15:00-15:15
Bio-Techne

15:15-15:30
AAC Infotray AG

15:30-15:45
DyNAbind GmbH

15:45-16:00
Nuvisan ICB GmbH

16:00-16:15
Johnson & Johnson Innovation Limited

16:15-16:30
Lexogen GmbH

16:30-16:45
Medicilon Inc

16:45-17:00
Addex Therapeutics Ltd.

17:00-17:15
Sino Biological Europe GmbH

17:15-17:30
Cambrex Corporation

17:30-17:45
Catenion GmbH

17:45-18:00
Springer-Verlag GmbH

18:00-18:15
Wuxi AppTec

presented by

12

Emerging Biotech Companies (Room Sydney)

14:45-15:00
Pureos Bioventures

15:00-15:15
Vandria

15:15-15:30
Noema Pharma

15:30-15:45
FimmCyte

15:45-16:00
Orion Biotechnology

16:00-16:15
Peptone

16:15-16:30
Incephalo

16:30-16:45
FoRx

16:45-17:00
LimmaTech Biologics

17:00-17:15
Asterivir

presented by

Clinical Stage Development Companies (Room Rio)

15:00 – 15:15
AC Bioscience SA

15:15 – 15:30
GeNeuro SA

15:30 – 15:45
Immunophotonics Switzerland

15:45 – 16:00
Molecular Partners

16:00 – 16:15
Endogena Therapeutics AG

16:15 – 16:30
Cellis AG

16:30 – 16:45
ARENSIA Exploratory Medicine GmbH

Panel Discussions (Room Montreal)

14:45 – 15:30 – Panel 1

Breaking Boundaries: The Emergence of Regenerative Medicine, Digital Technologies and Genomics

presented by

15:45 – 16:30 – Panel 2

Powering Precision Medicine Using Multi Level Data

presented by

16:45 – 17:30 – Panel 3

Opportunities of digitalisation in the healthcare system, relevance and benefits of data collection from citizens (incl. healthy citizens)

presented by

17:45 – 18:30 – Panel 4

The four dimensions of Switzerland’s contribution to Health Care systems around the world

presented by

Panel Discussions (Room Samarkand)

14:45 – 15:30 – Panel 5

How can Swiss biotechs remain competitive in a challenging environment for early stage financing and partnering?

presented by

15:45 – 16:30 – Panel 6

SBA Legal Tax & Accounting Chapter | Cluster Switzerland: New ways and opportunities

presented by

16:45 – 17:30 – Panel 7

Trends in Process Intensification for Biomanufacturing

presented by

17:45 – 18:30 – Panel 8

Swiss Biotech Association – Industrial Biotechnology Chapter. Solutions for global industrial challenges

presented by

Panel Discussions (Room Marriott Hotel)

14:45 – 15:30 – Panel 9

How to Scale for Growth: How to succeed in navigating key milestones such as funding, IPO, operational setup, and launch, which will define your future

presented by

15:45 – 16:30 – Panel 10

Set up for success: What have the past 25 years taught us about the future of biopharmaceutical innovation?

presented by

16:45 – 17:30 – Panel 11

Integrated evidence plan (IEP), an accelerator for drug development and market access

presented by

17:45 – 18:30 – Panel 12

RNA Therapeutics: The short, the long and genome editing

presented by

17:30-18:15

Venture Leaders Pitch

Venture Leaders Pitch (Room Singapore)

17:30 – 18:15	Discover the Venture Leaders Biotech opportunities Successful Venture Leaders alumni Ulf Grawunder will share his experience in building and selling NBE Therapeutics, a 1.1 bn exit, followed by pitches of selected biotech startups.	presented by
17:30	Opening and Venture Leaders Biotech introduction
17:35	Affivant Sciences GmbH
17:38	metaLead Therapeutics
17:41	Navignostics AG
17:44	Isospec Analytics SA
17:47	SURI BioTech GmbH
17:50	Limula SA
17:53	Tandem Therapeutics
17:56	ND Biosciences SA
17:59	Invasight AG
18:02	Mosanna Therapeutics AG
18:05	Voting for team captain selection
18:10	Debiopharm closing address

18:00-19:00

International Reception
Room San Francisco

18:30-21:00

Evening Reception
Foyer 2nd Floor

Tuesday, April 25, 2023

07:30

Registration open
Entrance

08:00-16:00

Partnering throughout the day
Room San Francisco

Partnering

Partnering

The partnering will open in March 2023.

Once you have registered, you will receive an automated acknowledgement to the email address you have registered with. We will create a free account in the Swiss Biotech Day online partnering system called “Hello Partnering” provided by BIOTECH GATE and VENTURE VALUATION. Once your account is set up you will receive a confirmation email containing your login details.

Meetings will be held on-site only in a dedicated area of the conference.

presented by

09:00-16:00

Global Village with Round Table Discussions throughout the day
Room San Francisco

Global Village

Welcome to the Global Village at the Swiss Biotech Day 2023.

The Global Village platform is a dedicated offering for national and regional foreign biotech clusters which intend to develop and strengthen long-term and sustainable business ties and collaborations with various stakeholders of the Swiss biotech ecosystem. It is an integral part of the Swiss Biotech Day as the anchor event for the Global Village platform. International delegations who participate in the Global Village platform benefit from several tailormade opportunities in addition to the classical offerings of the Swiss Biotech Day: they present themselves through dedicated delegation booths in the Global Village area of the Swiss Biotech Day, they participate in a small roundtable discussion tailormade for each delegation and they will be part of the international reception for foreign delegations. In addition, delegations may participate in dedicated site visits of selected biotech hotspots in Switzerland directly after the Swiss Biotech Day.

Delegations include a cross-section of their respective biotech hub including C-level entrepreneurs, venture builders and investors, researchers and academics, leading hospital representatives, clinical investigators and CROs, government bodies and economic development agencies to representatives of incubators and accelerators.

The Global Village Platform is jointly presented by the Swiss Biotech Association and Switzerland Global Enterprise.
All participants of the Swiss Biotech Day are welcome to explore the Global Village booths and engage with delegation members in the Global Village area of the Swiss Biotech Day.

presented by

Round Table Discussions

Round Table Discussions

Please join us for roundtable discussions, aiming to facilitate partnerships and connect international representatives with the Swiss biotech industry for research, corporate collaborations, policy-making and investments.

Join us at a bilateral roundtable discussion or have a drink with us at the international reception in the Global Village and network with the global biotech community!

Time

11:30-12:00

12:15-12:45

13:00-13:30

13:45-14:15

14:30-15:00

15:15-15:45

Country

Delegation of Queensland

Delegation of Thailand

09:00-16:00

Exhibition and poster presentation throughout the day
Foyer 2nd floor and Room Singapore

Exhibitors

09:30-11:30

Plenary Session II
Room Montreal

Plenary Session II

Moderator: Monika Jones

09:30	Welcome Address Michael Altorfer, CEO, Swiss Biotech Association
09:40	Global trends in biopharmaceutical innovation and outlook Alexandra Zemp, Partner, McKinsey Isma Hachi, Director Emerging BioPharma, IQVIA Daniel Chancellor, Consulting Director, Citeline Maurice Perrinjaquet, Partner, EY
10:10	Swiss Biotech Report 2023 Frederik Schmachtenberg, Partner, Global Life Sciences Lead for Financial Accounting Advisory Services, EY
10:30	Keynote by George Scangos, member of the Board of Directors at Vir Biotechnology George Scangos, Ph.D., has served as a member of the Vir Biotechnology Board of Directors since January 2017. He was the President and Chief Executive Officer of Vir from 2016 to 2023. From 2010 to 2016, he was Chief Executive Officer and a member of the board of directors of Biogen Inc., a publicly traded biopharmaceutical company focused on the treatment of serious diseases. From 1996 to 2010, he served as President and Chief Executive Officer of Exelixis, Inc., a drug discovery and development company. As President of Bayer Biotechnology, from 1993 to 1996, he was responsible for research, business development, process development, manufacturing, engineering, and quality assurance of Bayer Biotechnology’s biological products. Prior to joining industry, Dr. Scangos was a Professor of Biology at Johns Hopkins University and has also served on the board of various publicly traded companies.
11:00	Swiss Biotech Success Stories Award Luca Bolliger, jury president
11:20	Celebrating 25 years of the Swiss Biotech Association Cake Cutting Ceremony

11:30-12:30

Lunch
Foyer 2nd and 3rd Floor

presented by

11:45-13:15

Swiss Biotech Association Chapter: Lab Automation, Diagnostics and Analytics (Pitch)
Lab Automation and Diagnostics beyond 2030 (Panel Discussion)

Room Singapore

Company Pitches & Panel Discussion

11:45-11:55	Introduction Launch of a new SBA chapter evolving around laboratory sciences & automation, and the development of novel technologies and analysis pipelines for diagnostics and patient stratification, growingly powered by new possibilities stemming from digitalisation and customised IT solutions. After a short introduction, we will host pitches of selected startups embedded in this lively ecosystem. Swiss Biotech Association, Michael Altorfer, CEO Biotechnet, Samantha Paoletti, Head of Research and BD Life Science Technologies, CSEM Science Technologies Toolpoint, Hans Noser, Managing Director	presented by
11:55-12:00	Pitch 1 Deep Breath Intelligence	“Revolutionizing early disease detection through breath analysis”
12:00-12:05	Pitch 2 Clemedi	“A novel biomarker and first test of cure for latent tuberculosis”
12:05-12:10	Pitch 3 Diaxxo	“Diaxxo: rapid PCR tests”
12:10-12:15	Pitch 4 Accroma Labtec Ltd.	“Flexible, Automated Sample Preparation for Chemical Analysis”
12:15-12:20	Pitch 5 Oncobit	“Personalized cancer monitoring based on circulating tumor DNA”
12:20-12:25	Pitch 6 Kugelmeiers Ltd.	“Enabling unlimited cell therapies”
12:30-13:15	Panel Discussion	“Lab Automation and Diagnostics beyond 2030”

from 12:30

Parallel Tracks

Advanced Biotech Companies (Room Osaka)

12:30-12:45
Stücki Park

12:45-13:00
ClearView Healthcare Partners

13:00-13:15
CTI Clinical Trial and Consulting

13:15-13:30
Neo4j

13:30-13:45
Quanterix

13:45-14:00
Ardigen S.A.

14:00-14:15
TETEC

14:15-14:30
Elsevier B.V.

14:30-14:45
Becton Dickinson

14:45-15:00
Carl Zeiss AG

15:00-15:15
BIOIVT

15:15-15:30
Invest Hong Kong

15:30-15:45
Mercuri Urval

15:45-16:00
Pattern Computer Inc.

presented by

12

Emerging Biotech Companies (Room Sydney)

12:30-12:45

12:45-13:00

13:00-13:15

13:15-13:30

13:30-13:45

13:45-14:00

14:00-14:15

14:15-14:30

Break

14:30-14:45

Somagenetix

14:45-15:00
Healiva

presented by

Clinical Stage Development Companies (Room Rio)

12:30 – 12:45
STALICLA

12:45 – 13:00
Scandion Oncology

13:00 – 13:15
InnoMedica AG

13:15 – 13:30
Aurealis Therapeutics

13:30 – 13:45
ETHRIS GmbH

13:45 – 14:00
Alentis Therapeutics AG

Panel Discussions (Room Montreal)

12:30 – 13:15 – Panel 13

From bench to business – Steps to bring your development start-up to a commercial organization

presented by

13:30 – 14:15 – Panel 14

Microphysiological systems and advanced 3D in vitro models as tools for innovating preclinical drug discovery

presented by

14:30 – 15:15 – Panel 15

Early involvement of regulators to bring innovation to patients: Experience sharing by SWISSMEDIC Switzerland & ANVISA Brazil

presented by

15:30 – 16:15 – Panel 16

Cell and Gene Therapy revolution – how can Switzerland stay at the forefront?

presented by

Panel Discussions (Room Smarkand)

12:30 – 13:15 – Panel 17

Coming from abroad: What is it like to step into the Life Science industry in Switzerland?

presented by

13:30 – 14:15 – Panel 18

Talent in Biotech – How Switzerland shines?

presented by

14:30 – 15:15 – Panel 19

Venture Builders, when VCs become Founders

presented by

15:30 – 16:15 – Panel 20

Late-Stage Biotech – Creating Value Through Business Development

presented by

Panel Discussions (Room Marriott Hotel)

12:30 – 13:15 – Panel 21

Microbiome – the emergence of a new treatment paradigm across a wide range of disease areas

presented by

13:30 – 14:15 – Panel 22

Food for thought: trends in microbiome health-tech

presented by

14:30 – 15:15 – Panel 23

From early diagnosis to access to treatments for rare diseases – European and US perspectives

presented by

15:30 – 16:15 – Panel 24

Speed to Clinic

presented by

14:15-14:45

Coffee Break

16:00-18:00

Evening Reception
Foyer 2nd Floor

16:30

Draw of three prize winners
Foyer 2nd Floor

Subject to change without notice.

Exhibitors

Company	Booth no
Swiss Biotech Association	1
SBA & Friends	2
Suvoda LLC	3
Bio-Techne	4
SIX Swiss Exchange Ltd	5
Lexogen GmbH	6
PALL International Sàrl	7
Cambrex	8
IMCD Switzerland AG	9
Biopole	10
Citeline	11
ten23 health Valais AG	12
Chauvin Arnoux	13
CROss Alliance	14
Porton Pharma Solutions Ltd	15
ACROBiosystems Co., Ltd.	16
Novegene Europe	17
Innosuisse	18
Deloitte	19
Envirotainer	20
SAKK Consulting Center	21
Caidya	22
Hamilton Bonaduz AG	23
PURNA Pharmaceuticals NV/SA	24
CRB	25
IPS-Integrated Project Services GmbH	26
SGS Analytical Service Switzerland	27
YUMAB GmbH	28
KLIFO A/S	29
PolyPeptide Group AG	30
AnaPath Services GmbH	31
SFL Regulatory Affairs & Scientific Communication GmbH	32
Beckman Coulter Eurocenter SA	33
ECO SWISS	34
Schrödinger GmbH	35
MyData-TRUST	36
Vector Builder GmbH	37
LubioScience GmbH	38
DHL Express (Switzerland) Ltd.	39
Eurofins Biopharma	40
BD	41
Sino Biological Europe GmbH	42
Tigermed	43
Meco	44
Remap Consulting GmbH	45
Emergent BioSolutions	46
Unilabs	47
Advanced Clinical Switzerland GmbH	48
Raumedic SA	49
Valgenesis	50
ZETA	51
ProtaGene	52
DPS Group	53
Biotechnet Switzerland	54
CSEM	55
ExcellGene SA	56
Medicilon Inc	57
Northway	58
Chemie Brunschwig AG	59
WuXi AppTec	60
Bionter	61
pci Pharma Services	62
GXPManagers	63
Allucent	64
ProPharma	65
BIOCOM AG	66
Miltenyi Biotec B.V. & Co. KG	67
Jacobs	68
LYO-X & iBiologix	69
Microsynth	70
Pharmadule Morimatsu AB	71
Stemcell	72
Selvita	73